Elpiscience

Choose Language : EN

EN CN

EN | CN

Harnessing IMMUNOLOGY to Fight Cancer

OUR COMPANY

... capitalizes on the latest biology break-throughs to innovate and develop the next generation of cancer immunotherapies ...

Suzhou GMP Site Opening

1 / 24

view more

NEWS RELEASE

Elpiscience to Present Two Programs at The Society for Immunotherapy of Cancer (“SITC”) 2021 Annual Meeting
2021-10-22
Shanghai/Suzhou, China, and Maryland, US, October 22, 2021. Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global clinical-stage biopharmaceutical company focusing on di...
Elpiscience Announces CDE Clearance of IND Application for ES104, Next-frontier Anti-angiogenesis Drug
2021-10-15
Shanghai/Suzhou, China, October 15, 2021. Elpiscience Biopharma, a global clinical-stage biotech company focusing on the discovery and development of next-generation cancer immunot...

view more

Our Science

1 / 24